logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
R

Ross A. Soo

national university health system

69H指数
687论文数
1.9W被引数
收录论文 165
发表时间
logo
Biology, detection, and management of incidental pulmonary nodules: the emerging role of targeted treatments. A review of the current literature and future perspectives生物学、检测和管理意外性肺结节：靶向治疗的新兴作用。当前文献回顾与未来展望
errLung Cancer
IF4.4
err2026-08-03
err0
PREAI
errRoss A. Soo; Ji-Youn Han; James Chung-Man Ho; Calvin S.H. Ng; Lynette L.S. Teo; Elaine Shum; Sanjay Popat
err分享
err收藏
Asia-Pacific practical consensus in the management of adverse events related to Amivantamab-Based therapies in Non-Small cell lung cancer亚太地区关于非小细胞肺癌Amivantamab-Based疗法相关不良事件管理的实践共识
errLung Cancer
IF4.4
err2026-04-07
err0
PREAI
errRoss A. Soo; Pablo Fernandez-Penas; Molly Li; Pei Jye Voon; Junko Tanizaki; Jeng-Sen Tseng; Chris Tan; Xiao Rong Dong; Kumar Prabhash; Hye Ryun Kim; Kazuo Hasegawa; Nicole Parkinson; Julian Kam; Jairo Simoes; Marija McGeachie; Shun Lu; Nick Pavlakis
err分享
err收藏
Emerging treatment strategies for HER2-mutant NSCLC: Striving for selectivity, efficacy, and tolerabilityHER2突变非小细胞肺癌的新兴治疗策略：追求选择性、疗效和耐受性
errLung Cancer
IF4.4
err2026-03-21
err0
PREAI
errGerrina Ruiter; Xiuning Le; Ross A. Soo; Noboru Yamamoto; Nicolas Girard; Yi-Long Wu; Joshua K. Sabari; Ernest Nadal
err分享
err收藏
A cost-effectiveness analysis model of actionable genomic alteration testing strategies incorporating different modalities and sizes of next-generation sequencing panels in non-small-cell lung cancer非小细胞肺癌中可操作基因组改变检测策略的成本效益分析模型，该模型整合了不同模态和规模的下一代测序面板。
errTherapeutic Advances in Medical Oncology
IF4.2
err2025-12-21
err0
PREAI
errYvonne L. E. Ang; Jian Chun Matthew Ong; Yiqing Huang; Jia Li Low; Kenneth Sooi; Jorn Nützinger; Xiao Jun Wang; Meaghan Gibbs; Boon Cher Goh; Ross A. Soo
err分享
err收藏
High clinical actionability of a pan-cancer tissue-based combined DNA and RNA next generation sequencing assay in a diverse Asian population在多样化亚洲人群中，一种泛癌种基于组织的联合DNA和RNA下一代测序检测具有高度临床可操作性。
errnpj Precision Oncology
IF8
err2025-11-13
err0
errOAAI
errJing Yi Lee; Aya El Helali; Donavan Jia Jie Tan; Zi Yi Wan; Donald Poon; Jens Samol; Tsz Him So; Su Pin Choo; Ravindran Kanesvaran; Cheng-Vai Hui; Joseph Siu-Kie Au; Timothy Yip; Ross A. Soo; Michelle Pek; Ruifen Weng; Bin Tean Teh; Min-Han Tan; Jonathan Poh; Jason Yongsheng Chan
err分享
err收藏
A comparison of clinical guidelines; treatment characteristics and outcomes in small cell lung cancer between East Asia and Europe/North America东亚与欧洲/北美地区小细胞肺癌的临床指南比较；治疗特征与结局分析
errFrontiers in Oncology
IF3.3
err2025-10-27
err0
errOAAI
errChi-Lu Chiang; Ross Andrew Soo; Tony Mok; Pei Jye Voon; Lucksamon Thamlikitkul; Ying Cheng; Hidehito Horinouchi; Byong Chul Cho; Krista Lin Xu; Myung-Ju Ahn†
err分享
err收藏
The 2024 International Association for the Study of Lung Cancer (IASLC) Global Survey on Biomarker Testing2024年国际肺癌研究协会（IASLC）全球生物标志物检测调查
errJournal of Thoracic Oncology
IF20.8
err2025-07-22
err0
PREAI
errMatthew P. Smeltzer; Jennifer C. King; Casey Connolly; Kristin Brunson; Maiyan Chau; Shuyan Chen; Anna Kerpel-Fronius; Sylvie Lantuejoul; Anant Mohan; Allison Plaxco; Upal Basu Roy; Ricardo Santos; Ross Soo; Gavitt Woodard; Murry W. Wynes; Yasushi Yatabe; Amanda Young; Karen Kelly
err分享
err收藏
NEXUS: a phase I dose escalation study of selinexor plus nivolumab and ipilimumab in Asian patients with advanced/metastatic solid malignanciesNEXUS：一项在亚洲晚期/转移性实体瘤患者中进行的selinexor联合nivolumab和ipilimumab的I期剂量递增研究
errTherapeutic Advances in Medical Oncology
IF4.2
err2025-06-09
err0
errOAAI
errJoan R. Choo; Santhiay Nathan Jeraj; Raghav Sundar; Wei Peng Yong; Matilda Lee; Yiqing Huang; Yugarajah Asokumaran; Gloria H. J. Chan; Natalie Y. L. Ngoi; Andrea L. A. Wong; Ross A. Soo; Cheng Ean Chee; Joline S. J. Lim; Boon Cher Goh; Soo Chin Lee; David S. P. Tan
err分享
err收藏
A randomised non-comparative phase II study of atezolizumab, bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance - The ETOP 15-19 ABC-lung trial一项关于阿替利珠单抗、贝伐珠单抗和化疗在获得性耐药的EGFR突变非小细胞肺癌中的随机非对照II期研究——ETOP 15-19 ABC-lung试验
errLUNG CANCER
IF4.4
err2025-04-01
err0
PREAI
errSoo, R. A.; Vervita, K.; Fruh, M.; Cho, B. C.; Majem, M.; Abreu, D. Rodriguez; Ribi, K.; Callejo, A.; Moran, T.; Gomez, M. Domine; Provencio, M.; Addeo, A.; Han, J. Y.; Granados, A. L. Ortega; Reck, M.; Blasco, A.; Campelo, R. Garcia; Gonzalez, M. A. Sala; Britschgi, C.; Roschitzki-Voser, H.; Ruepp, B.; Gasca-Ruchti, A.; Haberecker, M.; Dafni, U.; Peters, S.; Stahel, R. A.
err分享
err收藏
First-Line Lorlatinib Versus Crizotinib in Asian Patients With Advanced ALK-Positive NSCLC: Five-Year Outcomes From the CROWN Study亚洲晚期ALK阳性NSCLC患者中，劳拉替尼一线治疗与克唑替尼的对比：CROWN研究五年结果
errJournal of Thoracic Oncology
IF20.8
err2025-02-28
err0
errOAAI
errYi-Long Wu; Hye Ryun Kim; Ross A. Soo; Qing Zhou; Hiroaki Akamatsu; Gee-Chen Chang; Chao-Hua Chiu; Hidetoshi Hayashi; Sang-We Kim; Yasushi Goto; Terufumi Kato; Jianying Zhou; Victor Ho-Fun Lee; Makoto Nishio; Baohui Han; Dong-Wan Kim; Shun Lu; Anna Polli; Jean-François Martini; Francesca Toffalorio; Tony Mok
err分享
err收藏
Will Sun-WUKONG, the monkey king, conquer EGFR exon 20 insertion mutation positive non-small cell lung cancer?孙悟空会攻克EGFR 20外显子插入突变阳性的非小细胞肺癌吗？
errTRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
err2025-02-01
err1
errOAAI
errLi, Molly; Soo, Ross A.
err分享
err收藏
Hierarchical clustering of immune checkpoint inhibitor- related pneumonitis in an Asian cohort of patients亚洲患者队列中免疫检查点抑制剂相关肺炎的层次聚类
errANNALS OF ONCOLOGY
IF65.4
err2024-12-01
err0
PREAI
errHuang, Y.; Lam, T.; Wong, A. S.; Zhao, J. J.; Tay, S. H.; Soo, R. . A.; Soo, Y. . Y.; Kee, A. C.
err分享
err收藏
Exosome autoantibody biomarkers for detection of lung cancer
errMILITARY MEDICAL RESEARCH
IF22.9
err2024-11-18
err0
errOAAI
errThuya, Win Lwin; Peyper, Janique Michelle; Myen, Tan Ti; Anuar, Nur Diana; Anwar, Arif; Gudimella, Ranga; Rutt, Nurul Huda; Rosli, Nurul Shielawati Mohamed; Badri, Noorul Hidayah; Rahman, Teh Norleila Abdul; Nurashirin, Raja; Sethi, Gautam; Tam, John Kit Chung; Wong, Andrea Li-Ann; Soo, Ross; Blackburn, Jonathan M.; Wang, Lingzhi; Goh, Boon Cher
err分享
err收藏
Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscape
errCANCER TREATMENT REVIEWS
IF10.5
err2024-11-01
err1
errOAAI
errWeller, Michael; Remon, Jordi; Rieken, Stefan; Vollmuth, Philipp; Ahn, Myung-Ju; Minniti, Giuseppe; Le Rhun, Emilie; Westphal, Manfred; Brastianos, Priscilla K.; Soo, Ross A.; Kirkpatrick, John P.; Goldberg, Sarah B.; Ohrling, Katarina; Hegi-Johnson, Fiona; Hendriks, Lizza E. L.
err分享
err收藏
Plain language summary: 5-year results from the CROWN study of lorlatinib vs crizotinib in non-small-cell lung cancer简明语言总结: 劳拉替尼与克唑替尼在非小细胞肺癌中的CROWN研究的5年结果
errFUTURE ONCOLOGY
IF2.6
err2024-10-03
err0
errOAAI
errSolomon, Benjamin J.; Liu, Geoffrey; Felip, Enriqueta; Mok, Tony S. K.; Soo, Ross A.; Mazieres, Julien; Shaw, Alice T.; de Marinis, Filippo; Goto, Yasushi; Wu, Yi-Long; Kim, Dong-Wan; Martini, Jean-Francois; Messina, Rossella; Paolini, Jolanda; Polli, Anna; Thomaidou, Despina; Toffalorio, Francesca; Bauer, Todd M.
err分享
err收藏
HER3 is widely expressed across diverse subtypes of NSCLC in a retrospective analysis of archived tissue samples
errFUTURE ONCOLOGY
IF2.6
err2024-09-25
err0
errOAAI
errSoo, Ross A.; Clinthorne, Graham; Santhanagopal, Anu; Wu, Chuntao; Karnoub, Maha; Patel, Parul; Bubendorf, Lukas
err分享
err收藏
Phase II open-label randomized study of pembrolizumab with or without bevacizumab in platinum-resistant recurrent/metastatic nasopharyngeal carcinoma (R/M NPC)II期开放标签随机研究：评估pembrolizumab联合或不联合bevacizumab治疗铂耐药复发/转移性鼻咽癌（R/M NPC）的疗效。
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err1
PREAI
errChong, W. Q.; Low, J. L.; Sooi, K.; Soo, R. A.; Le, C.; Teo, H. L.; Samol, J.; Goh, G.; Kong, L. R.; DasGupta, R.; Chia, S.; Wong, R.; Gopinathan, A.; Tay, J. K.; Eu, D.; Tsang, R.; Loh, K-S.; Tai, B. C.; Lim, Y. C.; Goh, B-C.
err分享
err收藏
First-line lorlatinib vs crizotinib in Asian patients with ALK plus non-small cell lung cancer (NSCLC): 5-year outcomes from the CROWN study一线洛拉替尼与克唑替尼在ALK阳性非小细胞肺癌（NSCLC）亚洲患者中的比较：CROWN研究5年结果
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errWu, Y-L.; Kim, H. R.; Soo, R. A.; Zhou, Q.; Akamatsu, H.; Chang, G-C.; Chiu, C. H.; Hayashi, H.; Kim, S-W.; Goto, Y.; Kato, T.; Zhou, J.; Lee, V. H. F.; Nishio, M.; Han, B.; Kim, D-W.; Lu, S.; Polli, A.; Martini, J-F.; Mok, T. S. K.
err分享
err收藏
Capmatinib plus nazartinib in patients with EGFR-mutated non-small cell lung cancer
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2024-09-01
err0
PREAI
errFelip, Enriqueta; Metro, Giulio; Soo, Ross A.; Wolf, Juergen; Solomon, Benjamin J.; Tan, Daniel S. W.; Ardizzoni, Andrea; Lee, Dae Ho; Sequist, Lecia V.; Barlesi, Fabrice; Ponce-Aix, Santiago; Abreu, Delvys Rodriguez; Campelo, Maria Rosario Garcia; Sprauten, Mette; Djentuh, Leslie O'Sullivan; Smith, Nathalie; Jary, Aline; Belli, Riccardo; Glaser, Sabine; Zou, Mike; Cui, Xiaoming; Giovannini, Monica; Yang, James Chih-Hsin
err分享
err收藏
Longitudinal probing of combinatorial immunotherapy (anti-VEGF/anti-PD1) response in advanced nasopharyngeal carcinoma, at single cell resolution高级鼻咽癌中组合免疫治疗（anti-VEGF/anti-PD1）反应的纵向探查，在单细胞分辨率水平
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errChia, S.; Shirgaonkar, N.; Lim, Y. C.; Tay, J. K.; Chong, W. Q.; Low, J. L.; Sooi, K.; Soo, R. A.; Teo, H. L.; Samol, J.; Goh, G.; Kong, L. R.; Gopinathan, A.; Eu, D.; Tsang, R.; Loh, K-S.; Tai, B. C.; Toh, H. C.; Goh, B-C.; DasGupta, R.
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
M
Matthew Meyerson
H 指数: 223 · 论文数: 1.9K
M
Michael Weller
H 指数: 175 · 论文数: 2.8K
E
Eric Van Cutsem
H 指数: 174 · 论文数: 1.8K
M
Markus M. Nöthen
H 指数: 161 · 论文数: 2.0K
C
Carlos Caldas
H 指数: 158 · 论文数: 1.4K
查看更多